Significant reduction of the mass of bone metastasis 1 year after rhenium-186 HEDP pain palliation therapy

Clinical Nuclear Medicine

Volumn 25, Issue 11, 2000, Pages 901-904

  Liepe, Knut ^a   Kropp, Joachim ^a   Hliscs, Rainer ^a   Franke, Wolf Gunter ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Mass Reduction of Bone Metastases; Pain Palliation; Prostate Cancer; Rhenium 186 HEDP

Indexed keywords

ANTIANDROGEN; DICLOFENAC; ETIDRONIC ACID; ETIDRONIC ACID RE 186; ETIDRONIC ACID TC 99M; FLUTAMIDE; GESTAGEN; GOSERELIN; LUTEINIZING HORMONE DERIVATIVE; MEGESTROL ACETATE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; BONE METASTASIS; BONE PAIN; BONE SCINTISCANNING; CANCER LOCALIZATION; CANCER PALLIATIVE THERAPY; CASE REPORT; HUMAN; MALE; PROSTATE CANCER; RADIOISOTOPE THERAPY;

BONE NEOPLASMS; ETIDRONIC ACID; HUMANS; MALE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PAIN; PALLIATIVE CARE; PROSTATIC NEOPLASMS; RADIOISOTOPES; RADIOPHARMACEUTICALS; RHENIUM; TECHNETIUM TC 99M MEDRONATE;

EID: 0033783377     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-200011000-00009     Document Type: Article

References (17)

1. Bone metastasis. Prognosis, diagnosis and treatment
2. Metastases from cancer of the prostate: Autopsy and roentgenological findings
3. Pharmacokinetics of rhenium-186 after administration of rhenium-186-HEDP to patients with bone metastases
4. 89Sr radionuclide therapy
5. Current status of systemic intravenous radiopharmaceuticals for the treatment of painful metastatic bone disease
6. Re-186(Sn) HEDP for treatment of multiple metastatic foci in bone: Human bio-distribution and dosimetric study
7. Bone marrow absorbed dose of rhenium-186-HEDP and the relationship with decreased platelet counts
8. Re-186 [Sn]HEDP for treatment of painful osseus metastases
9. Evaluation of thrombocytopenia in patients treated with rhenium-186-HEDP
10. Unsealed source therapy of painful bone metastases: An update
11. Rhenium-186 HEDP for treatment of painful metastases
12. Targeted radionuclide therapy for bone metastases
13. Efficacy of rhenium-186-etidronate in prostate cancer patients with metastatic bone pain
14. Dose escalation study of Rhenium-186 HEDP in patients with metastatic prostate cancer
15. Strontium-89: Treatment results and kinetics in patients with painful metastastic prostate and breast cancer in bone
16. Strontium-89 and low dose infusion cisplatin for patients with hormone refractory prostate carcinoma metastatic to bone: A preliminary report
17. Remission of bone metastases after combined chemotherapy and radionuclide therapy with Re-186 HEDP